MetLife (NYSE: MET) is one of 29 publicly-traded companies in the “Life & Health Insurance” industry, but how does it contrast to its peers? We will compare MetLife to related companies based on the strength of its analyst recommendations, institutional ownership, dividends, valuation, earnings, profitability and risk.
MetLife pays an annual dividend of $1.60 per share and has a dividend yield of 3.0%. MetLife pays out 1,778.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Life & Health Insurance” companies pay a dividend yield of 2.2% and pay out 35.9% of their earnings in the form of a dividend. MetLife has raised its dividend for 4 consecutive years.
Valuation and Earnings
This table compares MetLife and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|MetLife||$63.21 billion||$817.50 million||590.51|
|MetLife Competitors||$28.59 billion||$2.35 billion||53.79|
MetLife has higher revenue, but lower earnings than its peers. MetLife is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Risk and Volatility
MetLife has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, MetLife’s peers have a beta of 1.29, suggesting that their average stock price is 29% more volatile than the S&P 500.
This is a summary of recent ratings and recommmendations for MetLife and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
MetLife currently has a consensus target price of $58.24, indicating a potential upside of 9.59%. As a group, “Life & Health Insurance” companies have a potential upside of 7.69%. Given MetLife’s higher probable upside, analysts clearly believe MetLife is more favorable than its peers.
This table compares MetLife and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional and Insider Ownership
74.3% of MetLife shares are owned by institutional investors. Comparatively, 68.4% of shares of all “Life & Health Insurance” companies are owned by institutional investors. 0.3% of MetLife shares are owned by company insiders. Comparatively, 9.6% of shares of all “Life & Health Insurance” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
MetLife peers beat MetLife on 9 of the 15 factors compared.
MetLife Company Profile
MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses. Its Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. Latin America offers products, including life insurance, and retirement and savings products. Life insurance includes universal, variable and term life products. EMEA offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance.
Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.